| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CD8 receptor binding | 4.53e-10 | 9 | 105 | 5 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 4.53e-10 | 9 | 105 | 5 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 9.01e-10 | 10 | 105 | 5 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 9.01e-10 | 10 | 105 | 5 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 9.01e-10 | 10 | 105 | 5 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 2.81e-09 | 12 | 105 | 5 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 2.15e-08 | 17 | 105 | 5 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 5.32e-08 | 20 | 105 | 5 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 6.57e-07 | 32 | 105 | 5 | GO:0042288 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 2.66e-06 | 42 | 105 | 5 | GO:0071889 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 5.79e-06 | 49 | 105 | 5 | GO:0042605 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.34e-05 | 58 | 105 | 5 | GO:0042287 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 2.09e-04 | 161 | 105 | 6 | GO:0051087 | |
| GeneOntologyMolecularFunction | NAD+-protein-lysine ADP-ribosyltransferase activity | 2.71e-04 | 5 | 105 | 2 | GO:0140804 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 4.96e-04 | 532 | 105 | 10 | GO:0016755 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 7.80e-04 | 372 | 105 | 8 | GO:0061630 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 8.77e-04 | 473 | 105 | 9 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.20e-03 | 398 | 105 | 8 | GO:0061659 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 1.52e-03 | 512 | 105 | 9 | GO:0019787 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.80e-10 | 8 | 106 | 5 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.36e-08 | 16 | 106 | 5 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 1.92e-08 | 17 | 106 | 5 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.92e-08 | 17 | 106 | 5 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 2.65e-08 | 18 | 106 | 5 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.65e-08 | 18 | 106 | 5 | GO:0042590 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.02e-07 | 23 | 106 | 5 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.60e-07 | 25 | 106 | 5 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 1.60e-07 | 25 | 106 | 5 | GO:0002475 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 5.88e-07 | 32 | 106 | 5 | GO:0019883 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 1.07e-06 | 150 | 106 | 8 | GO:0002708 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 1.60e-06 | 70 | 106 | 6 | GO:0001913 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 2.11e-06 | 41 | 106 | 5 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 2.23e-06 | 74 | 106 | 6 | GO:0002711 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 2.38e-06 | 42 | 106 | 5 | GO:0001916 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.62e-06 | 169 | 106 | 8 | GO:0010977 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 3.15e-06 | 232 | 106 | 9 | GO:0002706 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 3.28e-06 | 79 | 106 | 6 | GO:0001912 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 3.40e-06 | 175 | 106 | 8 | GO:0002705 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 3.49e-06 | 235 | 106 | 9 | GO:0002822 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 4.68e-06 | 48 | 106 | 5 | GO:0002478 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 6.15e-06 | 88 | 106 | 6 | GO:0031343 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 6.16e-06 | 252 | 106 | 9 | GO:0002819 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 7.69e-06 | 53 | 106 | 5 | GO:0001914 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 1.20e-05 | 58 | 106 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.25e-05 | 150 | 106 | 7 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 1.82e-05 | 159 | 106 | 7 | GO:0002821 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 2.11e-05 | 294 | 106 | 9 | GO:0044706 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 2.14e-05 | 163 | 106 | 7 | GO:0002456 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 2.34e-05 | 111 | 106 | 6 | GO:0002709 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 2.74e-05 | 233 | 106 | 8 | GO:0031345 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 3.11e-05 | 309 | 106 | 9 | GO:0002703 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 4.37e-05 | 124 | 106 | 6 | GO:0001910 | |
| GeneOntologyBiologicalProcess | female pregnancy | 4.39e-05 | 249 | 106 | 8 | GO:0007565 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 4.51e-05 | 76 | 106 | 5 | GO:0048002 | |
| GeneOntologyBiologicalProcess | neuron projection development | HLA-B HLA-C SZT2 PLEKHG4 WNT3 ITSN1 HLA-E HLA-F HLA-H DAB1 POU4F1 POU4F2 CLIP1 ITPR1 CNTN5 KIAA1755 MINAR1 MMP2 | 9.11e-05 | 1285 | 106 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of cell killing | 1.12e-04 | 147 | 106 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 1.27e-04 | 290 | 106 | 8 | GO:0044703 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.35e-04 | 462 | 106 | 10 | GO:0002460 | |
| GeneOntologyBiologicalProcess | embryo implantation | 1.44e-04 | 97 | 106 | 5 | GO:0007566 | |
| GeneOntologyBiologicalProcess | neuron development | HLA-B HLA-C SZT2 PLEKHG4 WNT3 ITSN1 HLA-E HLA-F HLA-H DAB1 POU4F1 POU4F2 CLIP1 ITPR1 CNTN5 KIAA1755 SECISBP2 MINAR1 MMP2 | 1.53e-04 | 1463 | 106 | 19 | GO:0048666 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway | 1.56e-04 | 4 | 106 | 2 | GO:0002488 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 1.56e-04 | 4 | 106 | 2 | GO:0002489 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 1.59e-04 | 53 | 106 | 4 | GO:0030574 | |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | 2.33e-04 | 317 | 106 | 8 | GO:0002699 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 2.43e-04 | 497 | 106 | 10 | GO:0002697 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 2.59e-04 | 5 | 106 | 2 | GO:0002481 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class Ib | 2.59e-04 | 5 | 106 | 2 | GO:0002477 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | HLA-B HLA-C WNT3 HLA-E HLA-F HLA-H DAB1 POU4F2 CLIP1 ITPR1 MINAR1 | 3.11e-04 | 612 | 106 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 3.87e-04 | 6 | 106 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 4.13e-04 | 187 | 106 | 6 | GO:0001909 | |
| GeneOntologyBiologicalProcess | response to nutrient | 4.75e-04 | 192 | 106 | 6 | GO:0007584 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 5.16e-04 | 449 | 106 | 9 | GO:0002449 | |
| GeneOntologyBiologicalProcess | ribosome-associated ubiquitin-dependent protein catabolic process | 5.40e-04 | 7 | 106 | 2 | GO:1990116 | |
| GeneOntologyBiologicalProcess | cellular response to mechanical stimulus | 5.46e-04 | 73 | 106 | 4 | GO:0071260 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | CPEB2 POU4F2 LCT TMEM87A ITPR1 MMP24 FANCG HABP4 ARNT SERPINB13 GCLC SCN2A CPEB4 STK39 MMP2 PLEC MMP9 | 5.57e-04 | 1361 | 106 | 17 | GO:0009628 |
| GeneOntologyBiologicalProcess | protein catabolic process | PITHD1 USP13 TRAF2 RHBDF1 RC3H1 RNF13 HUWE1 CAPN10 GCLC RNF10 MMP2 PJA1 MMP9 ZNF598 HECTD1 | 5.70e-04 | 1115 | 106 | 15 | GO:0030163 |
| GeneOntologyBiologicalProcess | cellular response to external stimulus | 5.75e-04 | 74 | 106 | 4 | GO:0071496 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 6.36e-04 | 76 | 106 | 4 | GO:0042269 | |
| GeneOntologyBiologicalProcess | protein K63-linked ubiquitination | 6.36e-04 | 76 | 106 | 4 | GO:0070534 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 6.62e-04 | 371 | 106 | 8 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 6.62e-04 | 371 | 106 | 8 | GO:0104004 | |
| GeneOntologyBiologicalProcess | response to nutrient levels | 6.73e-04 | 566 | 106 | 10 | GO:0031667 | |
| GeneOntologyBiologicalProcess | protein autoubiquitination | 7.02e-04 | 78 | 106 | 4 | GO:0051865 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 7.60e-04 | 139 | 106 | 5 | GO:0019882 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 7.72e-04 | 80 | 106 | 4 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 8.87e-04 | 83 | 106 | 4 | GO:0002707 | |
| GeneOntologyBiologicalProcess | cellular response to estradiol stimulus | 9.03e-04 | 37 | 106 | 3 | GO:0071392 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 9.20e-04 | 9 | 106 | 2 | GO:0042270 | |
| GeneOntologyBiologicalProcess | cell killing | 1.05e-03 | 307 | 106 | 7 | GO:0001906 | |
| GeneOntologyBiologicalProcess | apoptotic signaling pathway | TRAF2 POU4F1 POU4F2 ITPR1 SGK3 GCLC SCN2A AATF GNAI2 MMP2 MMP9 | 1.10e-03 | 713 | 106 | 11 | GO:0097190 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.14e-03 | 40 | 106 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 1.14e-03 | 40 | 106 | 3 | GO:0045954 | |
| GeneOntologyBiologicalProcess | hyaluronan metabolic process | 1.14e-03 | 40 | 106 | 3 | GO:0030212 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 1.15e-03 | 10 | 106 | 2 | GO:0018879 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoplasmic translation | 1.15e-03 | 10 | 106 | 2 | GO:2000766 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP13 TRAF2 RC3H1 PARP3 RNF13 HUWE1 PARP10 ARNT GCLC RNF10 MINAR1 ZNF598 HECTD1 MED12 | 1.19e-03 | 1074 | 106 | 14 | GO:0043687 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.22e-03 | 41 | 106 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell cytokine production | 1.40e-03 | 11 | 106 | 2 | GO:0002729 | |
| GeneOntologyBiologicalProcess | cellular response to UV-A | 1.40e-03 | 11 | 106 | 2 | GO:0071492 | |
| GeneOntologyBiologicalProcess | protein poly-ADP-ribosylation | 1.40e-03 | 11 | 106 | 2 | GO:0070212 | |
| GeneOntologyBiologicalProcess | protein auto-ADP-ribosylation | 1.40e-03 | 11 | 106 | 2 | GO:0070213 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin production | 1.47e-03 | 95 | 106 | 4 | GO:0002637 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 1.50e-03 | 44 | 106 | 3 | GO:0002717 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.52e-03 | 96 | 106 | 4 | GO:0002704 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.55e-03 | 525 | 106 | 9 | GO:0009410 | |
| GeneOntologyBiologicalProcess | peripheral nervous system development | 1.64e-03 | 98 | 106 | 4 | GO:0007422 | |
| GeneOntologyBiologicalProcess | natural killer cell cytokine production | 1.67e-03 | 12 | 106 | 2 | GO:0002370 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell cytokine production | 1.67e-03 | 12 | 106 | 2 | GO:0002727 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 1.67e-03 | 166 | 106 | 5 | GO:0002698 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | TRAF2 PMS2 HLA-B HLA-C RC3H1 HLA-E HLA-F HLA-H POU4F1 POU4F2 TTBK1 GBP5 CRTAM STK39 MMP9 | 1.69e-03 | 1242 | 106 | 15 | GO:0002684 |
| GeneOntologyBiologicalProcess | response to oxygen levels | 1.70e-03 | 430 | 106 | 8 | GO:0070482 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.82e-03 | 47 | 106 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | Schwann cell development | 1.82e-03 | 47 | 106 | 3 | GO:0014044 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 1.82e-03 | 249 | 106 | 6 | GO:0035264 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 6.66e-11 | 7 | 107 | 5 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 7.90e-10 | 10 | 107 | 5 | GO:0042612 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 6.17e-09 | 14 | 107 | 5 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.88e-08 | 17 | 107 | 5 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.00e-07 | 23 | 107 | 5 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.93e-07 | 26 | 107 | 5 | GO:0042611 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 9.19e-07 | 35 | 107 | 5 | GO:0098553 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.34e-06 | 42 | 107 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 4.60e-06 | 48 | 107 | 5 | GO:0098576 | |
| GeneOntologyCellularComponent | cis-Golgi network | 4.92e-06 | 85 | 107 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | recycling endosome | 1.89e-05 | 222 | 107 | 8 | GO:0055037 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 1.92e-05 | 64 | 107 | 5 | GO:0012507 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 4.47e-05 | 125 | 107 | 6 | GO:0140534 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 6.76e-05 | 83 | 107 | 5 | GO:0030670 | |
| GeneOntologyCellularComponent | Golgi cisterna | 6.87e-05 | 135 | 107 | 6 | GO:0031985 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.11e-04 | 212 | 107 | 7 | GO:0030666 | |
| GeneOntologyCellularComponent | Golgi stack | 2.51e-04 | 171 | 107 | 6 | GO:0005795 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 2.56e-04 | 110 | 107 | 5 | GO:0030134 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.78e-04 | 112 | 107 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | side of membrane | TRAF2 STAB2 HLA-B HLA-C HLA-E HLA-F HLA-H ITGA10 LCT GBP5 CNTN5 GNAI2 GPC5 | 5.29e-04 | 875 | 107 | 13 | GO:0098552 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1S TRAF2 HLA-B HLA-C HLA-E HLA-F HLA-H ITGA10 ITGB4 SCN2A TRBV2 GNAI2 | 6.83e-04 | 785 | 107 | 12 | GO:0098797 |
| GeneOntologyCellularComponent | transport vesicle membrane | 7.81e-04 | 293 | 107 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | early endosome membrane | 7.83e-04 | 212 | 107 | 6 | GO:0031901 | |
| GeneOntologyCellularComponent | endocytic vesicle | 8.08e-04 | 384 | 107 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | brush border | 1.12e-03 | 152 | 107 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 1.29e-03 | 157 | 107 | 5 | GO:0045335 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.39e-03 | 11 | 107 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TRAF2 CYP26B1 RHBDF1 HLA-B HLA-C CYP4B1 DNAJC16 HLA-E HLA-F ATG2B HLA-H RNF13 ITPR1 RETREG1 UGT2B11 | 2.41e-03 | 1293 | 107 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TRAF2 CYP26B1 RHBDF1 HLA-B HLA-C CYP4B1 DNAJC16 HLA-E HLA-F ATG2B HLA-H RNF13 ITPR1 RETREG1 UGT2B11 | 2.52e-03 | 1299 | 107 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | coated vesicle | 2.54e-03 | 360 | 107 | 7 | GO:0030135 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.81e-03 | 114 | 107 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | cell cortex | 3.00e-03 | 371 | 107 | 7 | GO:0005938 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TRAF2 CYP26B1 RHBDF1 HLA-B HLA-C CYP4B1 DNAJC16 HLA-E HLA-F ATG2B HLA-H RNF13 ITPR1 RETREG1 UGT2B11 | 3.09e-03 | 1327 | 107 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | Golgi membrane | B4GALNT1 RHBDF1 HLA-B HLA-C HLA-E HLA-F HLA-H HUWE1 TMEM87A GBP5 | 3.89e-03 | 721 | 107 | 10 | GO:0000139 |
| GeneOntologyCellularComponent | coated vesicle membrane | 5.00e-03 | 215 | 107 | 5 | GO:0030662 | |
| HumanPheno | Aplasia of the bladder | 3.21e-06 | 5 | 36 | 3 | HP:0010477 | |
| HumanPheno | Elevated maternal circulating alpha-fetoprotein concentration | 3.21e-06 | 5 | 36 | 3 | HP:0011432 | |
| HumanPheno | Aplasia/Hypoplasia of the bladder | 3.60e-06 | 16 | 36 | 4 | HP:0010476 | |
| HumanPheno | Abnormal maternal serum screening | 1.77e-05 | 8 | 36 | 3 | HP:0011436 | |
| MousePheno | spinal cord inflammation | 4.07e-10 | 8 | 85 | 5 | MP:0030987 | |
| MousePheno | abnormal mature NK cell morphology | 6.82e-09 | 25 | 85 | 6 | MP:0013700 | |
| MousePheno | decreased immature NK cell number | 1.42e-08 | 14 | 85 | 5 | MP:0013666 | |
| MousePheno | decreased mature NK cell number | 5.94e-08 | 18 | 85 | 5 | MP:0013672 | |
| MousePheno | abnormal immature NK cell number | 8.03e-08 | 19 | 85 | 5 | MP:0013665 | |
| MousePheno | abnormal immature NK cell morphology | 8.03e-08 | 19 | 85 | 5 | MP:0013699 | |
| MousePheno | cystolithiasis | 1.79e-07 | 22 | 85 | 5 | MP:0011625 | |
| MousePheno | abnormal mature NK cell number | 2.86e-07 | 24 | 85 | 5 | MP:0013671 | |
| MousePheno | CNS inflammation | 8.64e-07 | 54 | 85 | 6 | MP:0006082 | |
| MousePheno | urolithiasis | 1.11e-06 | 31 | 85 | 5 | MP:0005360 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 7.45e-06 | 45 | 85 | 5 | MP:0004804 | |
| MousePheno | decreased gamma-delta T cell number | 9.26e-06 | 47 | 85 | 5 | MP:0008347 | |
| MousePheno | increased NK cell number | 1.02e-05 | 82 | 85 | 6 | MP:0008044 | |
| MousePheno | demyelination | 1.26e-05 | 85 | 85 | 6 | MP:0000921 | |
| MousePheno | abnormal gamma-delta T cell number | 6.11e-05 | 69 | 85 | 5 | MP:0008345 | |
| MousePheno | abnormal myelination | 6.65e-05 | 166 | 85 | 7 | MP:0000920 | |
| MousePheno | abnormal NK cell number | 8.32e-05 | 172 | 85 | 7 | MP:0008043 | |
| MousePheno | decreased NK cell number | 8.88e-05 | 120 | 85 | 6 | MP:0008045 | |
| MousePheno | increased CD4-positive, alpha-beta T cell number | 1.07e-04 | 241 | 85 | 8 | MP:0008074 | |
| MousePheno | abnormal gamma-delta T cell morphology | 1.10e-04 | 78 | 85 | 5 | MP:0008343 | |
| MousePheno | abnormal T cell activation | 1.11e-04 | 311 | 85 | 9 | MP:0001828 | |
| MousePheno | abnormal NK cell morphology | 1.23e-04 | 183 | 85 | 7 | MP:0005068 | |
| MousePheno | abnormal urinary bladder morphology | 1.26e-04 | 247 | 85 | 8 | MP:0000538 | |
| MousePheno | abnormal T cell physiology | TRAF2 HLA-B HLA-C RC3H1 HLA-E HLA-F HLA-H TGM2 CRTAM GNAI2 PLEC MMP9 | 2.04e-04 | 584 | 85 | 12 | MP:0002444 |
| MousePheno | increased alpha-beta T cell number | 5.97e-04 | 311 | 85 | 8 | MP:0012764 | |
| Domain | MHC_I_a_C | 3.05e-11 | 6 | 105 | 5 | IPR010579 | |
| Domain | MHC_I_C | 3.05e-11 | 6 | 105 | 5 | PF06623 | |
| Domain | MHC_I | 9.66e-08 | 21 | 105 | 5 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 9.66e-08 | 21 | 105 | 5 | IPR001039 | |
| Domain | - | 9.19e-06 | 24 | 105 | 4 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 9.19e-06 | 24 | 105 | 4 | IPR011161 | |
| Domain | C1-set | 1.30e-05 | 54 | 105 | 5 | PF07654 | |
| Domain | IGc1 | 1.55e-05 | 56 | 105 | 5 | SM00407 | |
| Domain | Ig/MHC_CS | 1.85e-05 | 58 | 105 | 5 | IPR003006 | |
| Domain | Ig_C1-set | 1.85e-05 | 58 | 105 | 5 | IPR003597 | |
| Domain | IG_MHC | 2.18e-05 | 60 | 105 | 5 | PS00290 | |
| Domain | MHC_I/II-like_Ag-recog | 6.01e-05 | 38 | 105 | 4 | IPR011162 | |
| Domain | Hemopexin_CS | 1.11e-04 | 17 | 105 | 3 | IPR018486 | |
| Domain | PG_binding_1 | 1.84e-04 | 20 | 105 | 3 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 1.84e-04 | 20 | 105 | 3 | IPR002477 | |
| Domain | CEBP_ZZ | 1.86e-04 | 4 | 105 | 2 | PF16366 | |
| Domain | RRM_7 | 1.86e-04 | 4 | 105 | 2 | PF16367 | |
| Domain | CEBP_ZZ | 1.86e-04 | 4 | 105 | 2 | IPR032296 | |
| Domain | Hemopexin-like_dom | 2.82e-04 | 23 | 105 | 3 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 2.82e-04 | 23 | 105 | 3 | IPR018487 | |
| Domain | HEMOPEXIN | 2.82e-04 | 23 | 105 | 3 | PS00024 | |
| Domain | - | 2.82e-04 | 23 | 105 | 3 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 2.82e-04 | 23 | 105 | 3 | PS51642 | |
| Domain | HX | 2.82e-04 | 23 | 105 | 3 | SM00120 | |
| Domain | M10A_MMP | 2.82e-04 | 23 | 105 | 3 | IPR033739 | |
| Domain | Hemopexin | 2.82e-04 | 23 | 105 | 3 | PF00045 | |
| Domain | Pept_M10A | 2.82e-04 | 23 | 105 | 3 | IPR021190 | |
| Domain | Peptidase_M10 | 3.21e-04 | 24 | 105 | 3 | PF00413 | |
| Domain | Peptidase_Metallo | 5.67e-04 | 29 | 105 | 3 | IPR006026 | |
| Domain | ZnMc | 5.67e-04 | 29 | 105 | 3 | SM00235 | |
| Domain | Calx_beta | 8.57e-04 | 8 | 105 | 2 | SM00237 | |
| Domain | Calx_beta | 1.10e-03 | 9 | 105 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.10e-03 | 9 | 105 | 2 | PF03160 | |
| Domain | CYSTEINE_SWITCH | 1.58e-03 | 41 | 105 | 3 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 1.81e-03 | 43 | 105 | 3 | IPR001818 | |
| Domain | - | 2.35e-03 | 13 | 105 | 2 | 2.10.10.10 | |
| Domain | FN_type2_col-bd | 2.73e-03 | 14 | 105 | 2 | IPR000562 | |
| Domain | FN2_2 | 2.73e-03 | 14 | 105 | 2 | PS51092 | |
| Domain | FN2_1 | 2.73e-03 | 14 | 105 | 2 | PS00023 | |
| Domain | fn2 | 2.73e-03 | 14 | 105 | 2 | PF00040 | |
| Domain | FN2 | 2.73e-03 | 14 | 105 | 2 | SM00059 | |
| Domain | zf-RING_2 | 3.12e-03 | 52 | 105 | 3 | PF13639 | |
| Domain | Pept_M10A_Zn_BS | 3.13e-03 | 15 | 105 | 2 | IPR021158 | |
| Domain | POU | 3.57e-03 | 16 | 105 | 2 | SM00352 | |
| Domain | POU_dom | 3.57e-03 | 16 | 105 | 2 | IPR000327 | |
| Domain | Pou | 3.57e-03 | 16 | 105 | 2 | PF00157 | |
| Domain | POU_1 | 3.57e-03 | 16 | 105 | 2 | PS00035 | |
| Domain | POU_2 | 3.57e-03 | 16 | 105 | 2 | PS00465 | |
| Domain | POU_3 | 3.57e-03 | 16 | 105 | 2 | PS51179 | |
| Domain | - | 3.83e-03 | 449 | 105 | 8 | 3.30.40.10 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 4.03e-03 | 17 | 105 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 4.03e-03 | 17 | 105 | 2 | PS51059 | |
| Domain | POU | 4.03e-03 | 17 | 105 | 2 | IPR013847 | |
| Domain | PARP | 4.03e-03 | 17 | 105 | 2 | PF00644 | |
| Domain | - | 4.03e-03 | 17 | 105 | 2 | 3.90.228.10 | |
| Domain | Znf_RING/FYVE/PHD | 4.37e-03 | 459 | 105 | 8 | IPR013083 | |
| Domain | PH | 4.85e-03 | 278 | 105 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.94e-03 | 279 | 105 | 6 | PS50003 | |
| Domain | PH_domain | 5.02e-03 | 280 | 105 | 6 | IPR001849 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 9.85e-10 | 9 | 87 | 5 | MM14527 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.01e-08 | 6 | 87 | 4 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.67e-08 | 7 | 87 | 4 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.67e-08 | 7 | 87 | 4 | M47530 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 6.41e-08 | 18 | 87 | 5 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.15e-07 | 20 | 87 | 5 | MM1374 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 3.84e-07 | 25 | 87 | 5 | MM15713 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 3.84e-07 | 25 | 87 | 5 | MM1465 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.32e-07 | 11 | 87 | 4 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 6.45e-07 | 12 | 87 | 4 | M47529 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.99e-05 | 54 | 87 | 5 | MM14871 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 2.38e-05 | 56 | 87 | 5 | MM15901 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 2.86e-05 | 29 | 87 | 4 | M1062 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 3.10e-05 | 98 | 87 | 6 | M965 | |
| Pathway | WP_TAR_SYNDROME | 4.23e-05 | 63 | 87 | 5 | M48082 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 7.65e-05 | 37 | 87 | 4 | M18615 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 1.04e-04 | 76 | 87 | 5 | MM14526 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.15e-04 | 41 | 87 | 4 | M13519 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 1.18e-04 | 78 | 87 | 5 | M973 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 1.39e-04 | 43 | 87 | 4 | M12617 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.85e-04 | 135 | 87 | 6 | MM14781 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 2.92e-04 | 52 | 87 | 4 | M13103 | |
| Pathway | WP_PROTEASOME_DEGRADATION | 5.75e-04 | 62 | 87 | 4 | M39639 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 6.65e-04 | 28 | 87 | 3 | M47655 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 7.39e-04 | 29 | 87 | 3 | MM15981 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 8.17e-04 | 30 | 87 | 3 | M39652 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 9.10e-04 | 70 | 87 | 4 | M12294 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY | 1.03e-03 | 8 | 87 | 2 | M47780 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 1.08e-03 | 33 | 87 | 3 | M26976 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 1.12e-03 | 74 | 87 | 4 | M48080 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 1.24e-03 | 343 | 87 | 8 | MM15712 | |
| Pathway | BIOCARTA_RECK_PATHWAY | 1.32e-03 | 9 | 87 | 2 | MM1579 | |
| Pathway | BIOCARTA_RECK_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M22068 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.32e-03 | 9 | 87 | 2 | MM15117 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.48e-03 | 273 | 87 | 7 | M983 | |
| Pathway | PID_FRA_PATHWAY | 1.52e-03 | 37 | 87 | 3 | M65 | |
| Pubmed | Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development. | 1.50e-12 | 6 | 107 | 5 | 30537346 | |
| Pubmed | A nonpolymorphic class I gene in the murine major histocompatibility complex. | 1.50e-12 | 6 | 107 | 5 | 6420070 | |
| Pubmed | Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. | 1.50e-12 | 6 | 107 | 5 | 6276751 | |
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 9730897 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 6411351 | ||
| Pubmed | Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k. | 1.50e-12 | 6 | 107 | 5 | 2639903 | |
| Pubmed | Characteristics of the expression of the murine soluble class I molecule (Q10). | 1.50e-12 | 6 | 107 | 5 | 3940270 | |
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 7836920 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 8283431 | ||
| Pubmed | QUOD ERAT FACIENDUM: sequence analysis of the H2-D and H2-Q regions of 129/SvJ mice. | 1.50e-12 | 6 | 107 | 5 | 12389096 | |
| Pubmed | Occurrence of a unique MHC class I gene in distantly related members of the genus Mus. | 1.50e-12 | 6 | 107 | 5 | 3988322 | |
| Pubmed | Correlation of Qa-1 determinants defined by antisera and by cytotoxic T lymphocytes. | 1.50e-12 | 6 | 107 | 5 | 2580784 | |
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 2228044 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 6304710 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 6822734 | ||
| Pubmed | Spatial-Temporal Expression of Non-classical MHC Class I Molecules in the C57 Mouse Brain. | 1.50e-12 | 6 | 107 | 5 | 26040564 | |
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 28894277 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 3925004 | ||
| Pubmed | Qa antigens and their differential distribution on lymphoid, myeloid and stem cells. | 1.50e-12 | 6 | 107 | 5 | 6399516 | |
| Pubmed | Polymorphism of a Qa-1-associated antigen defined by cytotoxic T cells. I. Qed-1a and Qed-1d. | 1.50e-12 | 6 | 107 | 5 | 6978819 | |
| Pubmed | Identification of a recombinogenic major histocompatibility complex Q gene with diverse alleles. | 1.50e-12 | 6 | 107 | 5 | 8496692 | |
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 2767053 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 6967411 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 7026427 | ||
| Pubmed | Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complex. | 1.50e-12 | 6 | 107 | 5 | 2740345 | |
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 6961454 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 2416805 | ||
| Pubmed | Recognition of alternate alleles and mapping of the Qa1 locus. | 1.50e-12 | 6 | 107 | 5 | 7276576 | |
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 8732475 | ||
| Pubmed | 1.50e-12 | 6 | 107 | 5 | 9368027 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 2592022 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 1705528 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 2808323 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 21088134 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 5.24e-12 | 7 | 107 | 5 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 5.24e-12 | 7 | 107 | 5 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 5.24e-12 | 7 | 107 | 5 | 2714856 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 5.24e-12 | 7 | 107 | 5 | 2391419 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 15671142 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 5.24e-12 | 7 | 107 | 5 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 5.24e-12 | 7 | 107 | 5 | 6242891 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 17512611 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 7018573 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 2642506 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 9037062 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 1840571 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 20957233 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 5.24e-12 | 7 | 107 | 5 | 11086076 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 12750360 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 5.24e-12 | 7 | 107 | 5 | 20974936 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 10704462 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 5.24e-12 | 7 | 107 | 5 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 5.24e-12 | 7 | 107 | 5 | 2584927 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 3496275 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 12147629 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 3458188 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 5.24e-12 | 7 | 107 | 5 | 1730883 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 5.24e-12 | 7 | 107 | 5 | 19004778 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 5.24e-12 | 7 | 107 | 5 | 6300850 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 5.24e-12 | 7 | 107 | 5 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 5.24e-12 | 7 | 107 | 5 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 5.24e-12 | 7 | 107 | 5 | 2906539 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 3013627 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 5.24e-12 | 7 | 107 | 5 | 3856254 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 3894562 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 27385590 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 5.24e-12 | 7 | 107 | 5 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 5.24e-12 | 7 | 107 | 5 | 18383043 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 16272298 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 5.24e-12 | 7 | 107 | 5 | 6956903 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 8833240 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 5.24e-12 | 7 | 107 | 5 | 6604582 | |
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 5.24e-12 | 7 | 107 | 5 | 6954478 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 34525366 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 3374494 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 5.24e-12 | 7 | 107 | 5 | 3025084 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 2543831 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 5.24e-12 | 7 | 107 | 5 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 5.24e-12 | 7 | 107 | 5 | 6786753 | |
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 6583704 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 6571712 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 9222352 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 12006653 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 1699529 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 17982076 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 7520098 | ||
| Pubmed | 5.24e-12 | 7 | 107 | 5 | 15644207 | ||
| Interaction | HLA-H interactions | 1.57e-06 | 17 | 105 | 4 | int:HLA-H | |
| Interaction | HLA-E interactions | 3.54e-06 | 79 | 105 | 6 | int:HLA-E | |
| Interaction | CD8A interactions | 9.52e-06 | 26 | 105 | 4 | int:CD8A | |
| Interaction | LILRB1 interactions | 1.61e-05 | 10 | 105 | 3 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 1.61e-05 | 10 | 105 | 3 | int:LILRB2 | |
| Interaction | MMP10 interactions | 1.72e-05 | 30 | 105 | 4 | int:MMP10 | |
| Interaction | SFTPC interactions | 2.13e-05 | 222 | 105 | 8 | int:SFTPC | |
| Interaction | MMP27 interactions | 2.20e-05 | 11 | 105 | 3 | int:MMP27 | |
| Interaction | HLA-G interactions | 3.56e-05 | 118 | 105 | 6 | int:HLA-G | |
| Interaction | NATD1 interactions | 3.78e-05 | 13 | 105 | 3 | int:NATD1 | |
| Interaction | UBE2D2 interactions | 4.32e-05 | 318 | 105 | 9 | int:UBE2D2 | |
| Interaction | ST8SIA4 interactions | 7.77e-05 | 84 | 105 | 5 | int:ST8SIA4 | |
| Interaction | KISS1 interactions | 8.86e-05 | 17 | 105 | 3 | int:KISS1 | |
| Cytoband | 6p21.3 | 3.11e-04 | 250 | 107 | 5 | 6p21.3 | |
| Cytoband | 1p36.11 | 5.53e-04 | 68 | 107 | 3 | 1p36.11 | |
| Cytoband | 2q24.3 | 6.32e-04 | 16 | 107 | 2 | 2q24.3 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.10e-06 | 44 | 76 | 5 | 588 | |
| GeneFamily | C1-set domain containing | 2.86e-05 | 42 | 76 | 4 | 591 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 1.36e-04 | 24 | 76 | 3 | 891 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.75e-03 | 206 | 76 | 5 | 682 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.28e-03 | 17 | 76 | 2 | 684 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 4.17e-03 | 23 | 76 | 2 | 523 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 4.35e-09 | 16 | 107 | 5 | MM3766 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 1.15e-08 | 19 | 107 | 5 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 1.15e-08 | 19 | 107 | 5 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 1.17e-08 | 39 | 107 | 6 | MM3725 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.52e-08 | 20 | 107 | 5 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.99e-08 | 21 | 107 | 5 | MM651 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 4.12e-08 | 24 | 107 | 5 | MM3773 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 5.14e-08 | 25 | 107 | 5 | MM672 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 1.02e-07 | 92 | 107 | 7 | MM3748 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 1.52e-07 | 59 | 107 | 6 | MM3688 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 1.61e-07 | 31 | 107 | 5 | MM3729 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | CACNA1S CYP26B1 HLA-B HLA-C SZT2 RC3H1 HLA-E HLA-F ATG2B HLA-H ISCA2 ITPR1 RAB4B MMP2 PLEC | 2.53e-07 | 723 | 107 | 15 | MM3672 |
| Coexpression | PAL_PRMT5_TARGETS_DN | 3.04e-07 | 35 | 107 | 5 | MM674 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 5.32e-07 | 39 | 107 | 5 | MM3758 | |
| Coexpression | HOWLIN_CITED1_TARGETS_1_UP | 6.88e-07 | 41 | 107 | 5 | MM710 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_4HR | 8.78e-07 | 43 | 107 | 5 | MM1204 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING | 9.87e-07 | 44 | 107 | 5 | MM3775 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 9.87e-07 | 44 | 107 | 5 | MM805 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING | 1.09e-06 | 82 | 107 | 6 | MM3858 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 1.24e-06 | 46 | 107 | 5 | MM3712 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | 1.26e-06 | 192 | 107 | 8 | MM752 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 | 1.45e-06 | 86 | 107 | 6 | MM834 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 1.54e-06 | 137 | 107 | 7 | MM16612 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 1.55e-06 | 87 | 107 | 6 | MM652 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 1.71e-06 | 49 | 107 | 5 | MM1287 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING | 1.89e-06 | 50 | 107 | 5 | MM3805 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ATRIAL_MYOCYTE_AGEING | 1.96e-06 | 142 | 107 | 7 | MM3703 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 2.05e-06 | 143 | 107 | 7 | MM1056 | |
| Coexpression | PILON_KLF1_TARGETS_UP | STAB2 RHBDF1 HLA-B HLA-C ITSN1 HLA-E HLA-F HLA-H HUWE1 CPEB4 UGT2B11 HECTD1 | 2.22e-06 | 541 | 107 | 12 | MM1061 |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 2.25e-06 | 145 | 107 | 7 | MM3744 | |
| Coexpression | HOLLERN_MICROACINAR_BREAST_TUMOR_UP | 2.30e-06 | 52 | 107 | 5 | MM968 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING | 2.30e-06 | 52 | 107 | 5 | MM3808 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_31 | 2.37e-06 | 209 | 107 | 8 | MM17088 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 2.94e-06 | 97 | 107 | 6 | MM3789 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 3.12e-06 | 98 | 107 | 6 | MM460 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CPEB2 KDM4C CYP4B1 ITSN1 HLA-E HLA-F PARD3B RNF13 CLIP1 CEMIP2 SGK3 ARNT CPEB4 RETREG1 SHE | 3.27e-06 | 888 | 107 | 15 | MM1018 |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 3.34e-06 | 56 | 107 | 5 | MM3852 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 3.51e-06 | 100 | 107 | 6 | MM458 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 3.65e-06 | 57 | 107 | 5 | MM3716 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_BRONCHIAL_SMOOTH_MUSCLE_CELL_AGEING | 3.66e-06 | 156 | 107 | 7 | MM3763 | |
| Coexpression | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR | 3.98e-06 | 58 | 107 | 5 | MM661 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 4.17e-06 | 103 | 107 | 6 | MM476 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING | 4.33e-06 | 59 | 107 | 5 | MM3704 | |
| Coexpression | YU_MYC_TARGETS_DN | 8.77e-06 | 68 | 107 | 5 | MM632 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CPEB2 KDM4C CYP4B1 ITSN1 HLA-E PARD3B RNF13 CLIP1 CEMIP2 SGK3 ARNT CPEB4 RETREG1 SHE | 1.00e-05 | 854 | 107 | 14 | M1533 |
| Coexpression | TABULA_MURIS_SENIS_HEART_VENTRICULAR_MYOCYTE_AGEING | 1.01e-05 | 120 | 107 | 6 | MM3710 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 1.12e-05 | 185 | 107 | 7 | MM1072 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 1.21e-05 | 124 | 107 | 6 | MM3726 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 1.24e-05 | 73 | 107 | 5 | M11428 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING | 1.33e-05 | 74 | 107 | 5 | MM3796 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING | 1.42e-05 | 75 | 107 | 5 | MM3759 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 1.42e-05 | 75 | 107 | 5 | MM3718 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 1.80e-05 | 199 | 107 | 7 | M9418 | |
| Coexpression | GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP | 1.80e-05 | 199 | 107 | 7 | M5105 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN | 1.86e-05 | 200 | 107 | 7 | M9586 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN | 1.86e-05 | 200 | 107 | 7 | M9576 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN | 1.86e-05 | 200 | 107 | 7 | M8572 | |
| Coexpression | GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP | 1.86e-05 | 200 | 107 | 7 | M4344 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | CPEB2 HLA-B HLA-C KDM4C DNAJC16 HLA-E HLA-F HLA-H TMEM87A CEMIP2 TGM2 SHANK2 GBP5 SECISBP2 STK39 | 1.97e-05 | 1033 | 107 | 15 | M4196 |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 2.19e-05 | 82 | 107 | 5 | MM3777 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 2.47e-05 | 84 | 107 | 5 | MM1049 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 | 2.61e-05 | 85 | 107 | 5 | MM1279 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 3.09e-05 | 88 | 107 | 5 | MM1087 | |
| Coexpression | COATES_MACROPHAGE_M1_VS_M2_DN | 3.44e-05 | 90 | 107 | 5 | MM750 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 3.44e-05 | 90 | 107 | 5 | MM3756 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 3.63e-05 | 91 | 107 | 5 | MM3720 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 4.03e-05 | 93 | 107 | 5 | MM1185 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | CRYBG2 HLA-B HLA-C HLA-E HLA-F HLA-H RBM42 ITPR1 RAB4B SECISBP2 MED12 | 4.20e-05 | 612 | 107 | 11 | MM3804 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | USP13 HLA-B HLA-C ITSN1 PARP3 HLA-E HLA-F HLA-H CLIP1 AATF PLEC | 4.45e-05 | 616 | 107 | 11 | MM977 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_NK_CELL_AGEING | 4.70e-05 | 96 | 107 | 5 | MM3834 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 5.64e-05 | 324 | 107 | 8 | MM3701 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 6.41e-05 | 330 | 107 | 8 | MM1120 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_PROMONOCYTE_AGEING | 6.88e-05 | 104 | 107 | 5 | MM3812 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING | 6.92e-05 | 246 | 107 | 7 | MM3713 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | HLA-B HLA-C PARP3 HLA-E HLA-F HLA-H SREK1 HUWE1 GCLC AATF PLEC | 8.14e-05 | 659 | 107 | 11 | MM1040 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_T_CELL_AGEING | 8.92e-05 | 445 | 107 | 9 | MM3853 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_B_CELL_AGEING | 9.38e-05 | 111 | 107 | 5 | MM3831 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 1.00e-04 | 352 | 107 | 8 | MM3788 | |
| Coexpression | ZHANG_UTERUS_C9_DENDRITIC_CELL | 1.06e-04 | 114 | 107 | 5 | MM16615 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 1.06e-04 | 114 | 107 | 5 | MM3799 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE | 1.07e-04 | 60 | 107 | 4 | M40971 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 1.15e-04 | 267 | 107 | 7 | MM1091 | |
| Coexpression | ZHANG_UTERUS_C5_MACROPHAGE | 1.21e-04 | 187 | 107 | 6 | MM16611 | |
| Coexpression | DURAND_STROMA_NS_UP | 1.48e-04 | 194 | 107 | 6 | MM962 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 1.56e-04 | 196 | 107 | 6 | M8135 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP | 1.61e-04 | 26 | 107 | 3 | M41741 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN | 1.65e-04 | 198 | 107 | 6 | M8859 | |
| Coexpression | GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 1.70e-04 | 199 | 107 | 6 | M8477 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 1.70e-04 | 126 | 107 | 5 | MM3711 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_VALVE_CELL_AGEING | 1.70e-04 | 126 | 107 | 5 | MM3709 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | HLA-B HLA-C HLA-E HLA-F HLA-H HUWE1 ITGB4 ITPR1 STOX2 HEPHL1 | 1.76e-04 | 600 | 107 | 10 | MM1025 |
| Coexpression | MA_RAT_AGING_UP | 1.77e-04 | 127 | 107 | 5 | MM16096 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_FIBROBLAST_AGEING | 1.77e-04 | 127 | 107 | 5 | MM3856 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | B4GALNT1 CYP26B1 HLA-B HLA-C HLA-F PARD3B POU4F1 POU4F2 TIGD3 GAB3 AATF GPC5 MMP2 PLEC | 1.78e-04 | 1115 | 107 | 14 | M10371 |
| Coexpression | RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP | 2.01e-04 | 28 | 107 | 3 | M3169 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 2.12e-04 | 132 | 107 | 5 | MM841 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | HLA-B HLA-C CYP4B1 HLA-E HLA-F HLA-H SREK1 GCLC AATF PJA1 PLEC | 2.26e-04 | 741 | 107 | 11 | MM1037 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 2.33e-04 | 211 | 107 | 6 | MM17081 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 2.43e-04 | 136 | 107 | 5 | MM3747 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 2.45e-04 | 302 | 107 | 7 | MM1046 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_activated|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.34e-08 | 194 | 107 | 8 | e3f288b58525c1f34db4459d3e83e0df695adfc7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-08 | 199 | 107 | 8 | a3ec743b978ba8fdf1677b4971b5731f50ddd30f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-07 | 173 | 107 | 7 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.93e-07 | 182 | 107 | 7 | f857b32de19240a8aca1685f7a78b4e53b04875c | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.52e-07 | 187 | 107 | 7 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-07 | 188 | 107 | 7 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-07 | 189 | 107 | 7 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 3.78e-07 | 189 | 107 | 7 | e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-07 | 190 | 107 | 7 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-07 | 190 | 107 | 7 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.06e-07 | 191 | 107 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | T/NK_cells-CD8+_Effector_T_cell|World / Lineage and Cell class | 4.35e-07 | 193 | 107 | 7 | 79fa0f482cd98642b1d38835cda98622f21e5bd0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8|bone_marrow / Manually curated celltypes from each tissue | 4.66e-07 | 195 | 107 | 7 | ed4e2275dac47cc9fb9c381e3f80fed0ce50b074 | |
| ToppCell | (1)_T_CD8_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.66e-07 | 195 | 107 | 7 | 2253590339b87692d350f9ea3d2aa851179967e1 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 4.83e-07 | 196 | 107 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.83e-07 | 196 | 107 | 7 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.00e-07 | 197 | 107 | 7 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 5.00e-07 | 197 | 107 | 7 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.00e-07 | 197 | 107 | 7 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-07 | 197 | 107 | 7 | e70e7d97823a762def3970d94a0e897981a6c922 | |
| ToppCell | mild-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.00e-07 | 197 | 107 | 7 | 8b0e4012e25641c3bcd3e9911031e43d9dbbff21 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-07 | 197 | 107 | 7 | bce0135a96910d2bace62a3408a1a6fdac0cf0df | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.00e-07 | 197 | 107 | 7 | 2e402a1d5a49c9943a165596dcc6fa89fcecb09c | |
| ToppCell | (1)_T_CD8_CytT|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.00e-07 | 197 | 107 | 7 | 804cec3b1839562dc027a5a2a1e015919bd31de7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-07 | 199 | 107 | 7 | 9b02acae6325b0ac9642438a4431285ff396e5fe | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Severe / Disease, condition lineage and cell class | 5.53e-07 | 200 | 107 | 7 | 31859b8db7ea17e48b7b54e92f0d76aeb755e7ca | |
| ToppCell | severe-CD8+_Tem|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.53e-07 | 200 | 107 | 7 | aaa2cd326dc15dee2fd975ca133359c5826f6a75 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-gd_T|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.53e-07 | 200 | 107 | 7 | 498a2632b111fbf2cd4d755e53698ac5573ba763 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD8+_Tem|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.53e-07 | 200 | 107 | 7 | cba63f8f2e7530e5539f7f5d93b3bcf5d693f6b9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 161 | 107 | 6 | 2a721b6228045adb2dfbcd4990d371f961dc5dc2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.39e-06 | 169 | 107 | 6 | 17568e7aacfdcd96c469bae57d5ffad04954e9bd | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_Natural_Killer_Cell|Airway / Age, Tissue, Lineage and Cell class | 3.88e-06 | 173 | 107 | 6 | 054cb468a2a10a96aa1d971618993f6777569e14 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.57e-06 | 178 | 107 | 6 | a96941fef62c2f4533c557ef825ae3265f8f52db | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-06 | 179 | 107 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.36e-06 | 183 | 107 | 6 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.36e-06 | 183 | 107 | 6 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-06 | 183 | 107 | 6 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.36e-06 | 183 | 107 | 6 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.53e-06 | 184 | 107 | 6 | 73eaac74a88bf5fd23d88035fac398ac43b268c5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.53e-06 | 184 | 107 | 6 | 65f651d4b93ed0b52f526d3f517d92b6c62aaec3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.53e-06 | 184 | 107 | 6 | 9001d35cdde061d06f8545b3cee942d1299129db | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-06 | 184 | 107 | 6 | 5b4f18b26d03e8e5798cac70d124534749fc4cc0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.71e-06 | 185 | 107 | 6 | 03df43e9c2ce4ec24ffed8e4e2993f94ba951c8b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.71e-06 | 185 | 107 | 6 | dbdbd6593cd98550238519746bb45fbf0617550b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.71e-06 | 185 | 107 | 6 | fb84fcf7f51f53489bcb3962fa9cb483e48257ed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.71e-06 | 185 | 107 | 6 | de2c24719946d5a37a982d816776cea7f3984c49 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.89e-06 | 186 | 107 | 6 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.89e-06 | 186 | 107 | 6 | 9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-06 | 188 | 107 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.26e-06 | 188 | 107 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-06 | 188 | 107 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 189 | 107 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 189 | 107 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 6.65e-06 | 190 | 107 | 6 | e1f474dc36bf9eaf457b14a8761d287904754cdc | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.65e-06 | 190 | 107 | 6 | be281c7c717c11ef3c5cbccd22628acf1bd9727f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 190 | 107 | 6 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|metastatic_Brain / Location, Cell class and cell subclass | 6.85e-06 | 191 | 107 | 6 | b98367fdb56ccb335d61035e69cd43c61a7fa816 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 6.85e-06 | 191 | 107 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.85e-06 | 191 | 107 | 6 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 7.06e-06 | 192 | 107 | 6 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-06 | 192 | 107 | 6 | fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.06e-06 | 192 | 107 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.06e-06 | 192 | 107 | 6 | 4e63d95f75fe6eb3f817e84528883e95093c5bbd | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.06e-06 | 192 | 107 | 6 | 7a122505d7adf236e0cbd9bcbc98e7c537600ca3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.06e-06 | 192 | 107 | 6 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | Control|World / Disease condition and Cell class | 7.27e-06 | 193 | 107 | 6 | 92347e919c8425f33692e121df6ca5d841748f6c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.27e-06 | 193 | 107 | 6 | aaf681f16f310168e4719464814a1fc0a2f8431a | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.49e-06 | 194 | 107 | 6 | 9344556b375fd9267652cdca57b2cbd50a878a1e | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.49e-06 | 194 | 107 | 6 | 13c3674d601c8a7355ce869de1af6401938c0037 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 7.49e-06 | 194 | 107 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.49e-06 | 194 | 107 | 6 | 866a9ca4c93c3c79c709a9d00def5392197f7e18 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.49e-06 | 194 | 107 | 6 | 9116451614431e3cf9bd7d4d626bf4bd23420e36 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 7.49e-06 | 194 | 107 | 6 | f0ababe8daa57f6827a3e2e72c884d9e8b2687a3 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD8+_T|normal_Lymph_Node / Location, Cell class and cell subclass | 7.49e-06 | 194 | 107 | 6 | 81b8f60d3b81e494051721ce9b8b6aefd415442c | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD8_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 7.49e-06 | 194 | 107 | 6 | fa53f1aab2f5923e90f090e10e3560b583441dc4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.49e-06 | 194 | 107 | 6 | 95ab357d5f7bf91ba287417928c8575e655814fc | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.49e-06 | 194 | 107 | 6 | 72749ab1dd36a0d58624328961e1db08ccba2686 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-06 | 195 | 107 | 6 | f55ab1018a6cde7d517b53e6ce44c3f7bde485c4 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.71e-06 | 195 | 107 | 6 | 1af6fd96634236d5910fd085ff2d532862303d6b | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-06 | 195 | 107 | 6 | ea1b00805391dca8be0883b635768b296369919a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.71e-06 | 195 | 107 | 6 | 073593a7f668512d1fbbb49efb0c20b736c79ff8 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 7.71e-06 | 195 | 107 | 6 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | normal_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 7.71e-06 | 195 | 107 | 6 | 3af8ea15e2ac8efdeb4d4f69357b83b8dbcfab8d | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 7.71e-06 | 195 | 107 | 6 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-06 | 195 | 107 | 6 | 85df110f753f58ab017018c54ee454edb4428e29 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.71e-06 | 195 | 107 | 6 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | control-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.71e-06 | 195 | 107 | 6 | 55b9052336cab3e769a126ecaeef267d8e7bcaa8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.71e-06 | 195 | 107 | 6 | 6774c9f7fa54045aaa35fbd0695e43748da2b293 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.71e-06 | 195 | 107 | 6 | 730c613cf6f4d16ca51fd44de1f5a883f615c5c5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.71e-06 | 195 | 107 | 6 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.94e-06 | 196 | 107 | 6 | 91902e135c05d1214d915c8d8e6037929c2501b8 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.94e-06 | 196 | 107 | 6 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.94e-06 | 196 | 107 | 6 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CytT|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.94e-06 | 196 | 107 | 6 | 3a4ba9ca84ce6b35038765da8c55812587b58bc2 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 7.94e-06 | 196 | 107 | 6 | 092caba6726d1acd409a8be335100764d0724e64 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 7.94e-06 | 196 | 107 | 6 | 2bf0f36af1d0934c03999dbbff3c51ae9432386d | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.17e-06 | 197 | 107 | 6 | e513d448385d5a8dbf68fb2b0892971cd841ae28 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 8.17e-06 | 197 | 107 | 6 | 13e6611cde9364f0c1bf681b0b26c4d2725e5f4a | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.17e-06 | 197 | 107 | 6 | 4b480a527bc1d77e35b310287be8741e5f62b7f0 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.17e-06 | 197 | 107 | 6 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| Computational | Genes in the cancer module 293. | 7.40e-07 | 12 | 69 | 4 | MODULE_293 | |
| Computational | Genes in the cancer module 143. | 1.48e-06 | 14 | 69 | 4 | MODULE_143 | |
| Computational | Neighborhood of PTPN6 | 1.17e-05 | 47 | 69 | 5 | GNF2_PTPN6 | |
| Computational | Neighborhood of CD48 | 4.88e-05 | 32 | 69 | 4 | GNF2_CD48 | |
| Computational | Neighborhood of VAV1 | 7.85e-05 | 36 | 69 | 4 | GNF2_VAV1 | |
| Computational | Neighborhood of INPP5D | 1.59e-04 | 43 | 69 | 4 | GNF2_INPP5D | |
| Computational | Neighborhood of HLA-C | 2.25e-04 | 47 | 69 | 4 | GNF2_HLA_C | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.87e-04 | 50 | 69 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Neighborhood of CD53 | 5.08e-04 | 58 | 69 | 4 | GNF2_CD53 | |
| Computational | Genes in the cancer module 210. | 7.39e-04 | 28 | 69 | 3 | MODULE_210 | |
| Computational | Neighborhood of PTPRC | 9.30e-04 | 68 | 69 | 4 | GNF2_PTPRC | |
| Computational | Neighborhood of STAT6 | 1.63e-03 | 79 | 69 | 4 | GNF2_STAT6 | |
| Drug | 2e A | 3.39e-06 | 7 | 106 | 3 | CID011840906 | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; HL60; HG-U133A | 3.98e-06 | 197 | 106 | 8 | 1429_DN | |
| Drug | dioxin | CYP26B1 RHBDF1 CYP4B1 CEMIP2 TGM2 ARNT GCLC MMP2 PLEC UGT2B11 | 5.18e-06 | 347 | 106 | 10 | CID000015625 |
| Drug | ND 322 | 2.15e-05 | 2 | 106 | 2 | ctd:C568509 | |
| Drug | KJ-2 | 2.15e-05 | 2 | 106 | 2 | CID006102757 | |
| Drug | AC1Q62J9 | 2.15e-05 | 2 | 106 | 2 | CID000475273 | |
| Drug | Ro 28-2653 | 2.15e-05 | 2 | 106 | 2 | ctd:C453902 | |
| Drug | S 3304 | 2.15e-05 | 2 | 106 | 2 | ctd:C503948 | |
| Drug | pipoxolan | 2.15e-05 | 2 | 106 | 2 | ctd:C000121 | |
| Drug | matlystatin B | 2.15e-05 | 2 | 106 | 2 | CID000132321 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 3.50e-05 | 194 | 106 | 7 | 433_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.74e-05 | 196 | 106 | 7 | 1628_DN | |
| Drug | plakin | 4.08e-05 | 82 | 106 | 5 | CID000018752 | |
| Drug | 2-aminofluorene | 5.26e-05 | 16 | 106 | 3 | ctd:C012177 | |
| Drug | AC1L916B | 6.36e-05 | 17 | 106 | 3 | CID000436250 | |
| Drug | abacavir | 6.36e-05 | 17 | 106 | 3 | ctd:C106538 | |
| Drug | SU 1498 | 6.42e-05 | 3 | 106 | 2 | ctd:C483044 | |
| Drug | Captopril | 6.42e-05 | 3 | 106 | 2 | DB01197 | |
| Drug | zosterin | 6.42e-05 | 3 | 106 | 2 | ctd:C070927 | |
| Drug | AMD 6221 | 6.42e-05 | 3 | 106 | 2 | ctd:C453459 | |
| Drug | SB 3CT compound | 6.42e-05 | 3 | 106 | 2 | ctd:C429533 | |
| Drug | delta-(3,4-dihydroxyphenyl)-gamma-valerolactone | 6.42e-05 | 3 | 106 | 2 | CID000152432 | |
| Drug | 4-(4-(4-fluorophenoxy)benzenesulfonylamino)tetrahydropyran-4-carboxylic acid hydroxyamide | 6.42e-05 | 3 | 106 | 2 | ctd:C532757 | |
| Drug | alpha-benzoylamino-1,4-naphthoquinone | 6.42e-05 | 3 | 106 | 2 | ctd:C109682 | |
| Drug | CP-471,358 | 6.42e-05 | 3 | 106 | 2 | ctd:C495612 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 5.25e-09 | 7 | 105 | 4 | DOID:0081267 (implicated_via_orthology) | |
| Disease | Junctional epidermolysis bullosa with pyloric atresia | 1.25e-05 | 2 | 105 | 2 | cv:C5676875 | |
| Disease | pyoderma gangrenosum (is_marker_for) | 1.25e-05 | 2 | 105 | 2 | DOID:8553 (is_marker_for) | |
| Disease | Sweet syndrome (is_marker_for) | 1.25e-05 | 2 | 105 | 2 | DOID:0080746 (is_marker_for) | |
| Disease | Epidermolysis Bullosa Simplex With Pyloric Atresia | 1.25e-05 | 2 | 105 | 2 | C2677349 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA | 1.25e-05 | 2 | 105 | 2 | 226730 | |
| Disease | heart valve disease (is_marker_for) | 3.75e-05 | 3 | 105 | 2 | DOID:4079 (is_marker_for) | |
| Disease | pulmonary embolism (implicated_via_orthology) | 3.75e-05 | 3 | 105 | 2 | DOID:9477 (implicated_via_orthology) | |
| Disease | Sturge-Weber syndrome (is_marker_for) | 3.75e-05 | 3 | 105 | 2 | DOID:0111563 (is_marker_for) | |
| Disease | Epidermolysis bullosa with pyloric atresia | 3.75e-05 | 3 | 105 | 2 | C1856934 | |
| Disease | Hypertensive disease | 6.25e-05 | 190 | 105 | 6 | C0020538 | |
| Disease | Lupus Nephritis | 7.49e-05 | 4 | 105 | 2 | C0024143 | |
| Disease | thoracic aortic aneurysm (biomarker_via_orthology) | 7.49e-05 | 4 | 105 | 2 | DOID:14004 (biomarker_via_orthology) | |
| Disease | occupational asthma (is_implicated_in) | 7.49e-05 | 4 | 105 | 2 | DOID:0080820 (is_implicated_in) | |
| Disease | stomach carcinoma (biomarker_via_orthology) | 7.49e-05 | 4 | 105 | 2 | DOID:5517 (biomarker_via_orthology) | |
| Disease | allergic asthma (is_implicated_in) | 1.25e-04 | 5 | 105 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | renal hypertension (implicated_via_orthology) | 1.25e-04 | 5 | 105 | 2 | DOID:1073 (implicated_via_orthology) | |
| Disease | Aortic Rupture | 1.25e-04 | 5 | 105 | 2 | C0003496 | |
| Disease | adrenoleukodystrophy (is_marker_for) | 1.25e-04 | 5 | 105 | 2 | DOID:10588 (is_marker_for) | |
| Disease | Aortic Aneurysm, Ruptured | 1.25e-04 | 5 | 105 | 2 | C0741160 | |
| Disease | pulmonary emphysema (biomarker_via_orthology) | 1.86e-04 | 6 | 105 | 2 | DOID:9675 (biomarker_via_orthology) | |
| Disease | Aortic Diseases | 1.86e-04 | 6 | 105 | 2 | C0003493 | |
| Disease | Aplasia Cutis Congenita | 1.86e-04 | 6 | 105 | 2 | C0282160 | |
| Disease | Neointima Formation | 1.86e-04 | 6 | 105 | 2 | C2936381 | |
| Disease | Neointima | 1.86e-04 | 6 | 105 | 2 | C2936380 | |
| Disease | Intellectual Disability | 2.02e-04 | 447 | 105 | 8 | C3714756 | |
| Disease | Aortic Aneurysm, Thoracic | 2.60e-04 | 7 | 105 | 2 | C0162872 | |
| Disease | level of oxylipin in blood plasma | 2.60e-04 | 7 | 105 | 2 | OBA_2050338 | |
| Disease | Aortic Aneurysm, Thoracoabdominal | 2.60e-04 | 7 | 105 | 2 | C0340630 | |
| Disease | cardiomyopathy (is_marker_for) | 2.60e-04 | 7 | 105 | 2 | DOID:0050700 (is_marker_for) | |
| Disease | Bone neoplasms | 3.46e-04 | 8 | 105 | 2 | C0005967 | |
| Disease | Malignant Bone Neoplasm | 3.46e-04 | 8 | 105 | 2 | C0279530 | |
| Disease | Marfan Syndrome, Type I | 4.44e-04 | 9 | 105 | 2 | C4721845 | |
| Disease | abdominal aortic aneurysm (implicated_via_orthology) | 4.44e-04 | 9 | 105 | 2 | DOID:7693 (implicated_via_orthology) | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 5.54e-04 | 10 | 105 | 2 | DOID:7693 (is_marker_for) | |
| Disease | cholesteatoma (is_marker_for) | 5.54e-04 | 10 | 105 | 2 | DOID:869 (is_marker_for) | |
| Disease | visceral:gluteofemoral adipose tissue ratio measurement | 5.57e-04 | 45 | 105 | 3 | EFO_0803319 | |
| Disease | cognitive function measurement | HLA-B SZT2 KDM4C WNT3 STARD10 HLA-F PARD3B STOX2 CNTN5 SCN2A CPEB4 RNF10 GNAI2 ATIC | 5.62e-04 | 1434 | 105 | 14 | EFO_0008354 |
| Disease | platelet crit | PDE4A STAG1 HLA-B HLA-E SH3BP4 ACTR1A HABP4 CNTN5 ARHGAP25 PJA1 PLEC | 5.86e-04 | 952 | 105 | 11 | EFO_0007985 |
| Disease | fibrinogen measurement | 6.32e-04 | 109 | 105 | 4 | EFO_0004623 | |
| Disease | beta-2 microglobulin measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0005197 | |
| Disease | Marfan Syndrome | 6.76e-04 | 11 | 105 | 2 | C0024796 | |
| Disease | diabetic retinopathy (is_implicated_in) | 7.60e-04 | 50 | 105 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | Centriacinar Emphysema | 8.09e-04 | 12 | 105 | 2 | C0221227 | |
| Disease | Panacinar Emphysema | 8.09e-04 | 12 | 105 | 2 | C0264393 | |
| Disease | Focal Emphysema | 8.09e-04 | 12 | 105 | 2 | C2350878 | |
| Disease | intracranial aneurysm (is_implicated_in) | 8.09e-04 | 12 | 105 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Mouth Diseases | 8.09e-04 | 12 | 105 | 2 | C0026636 | |
| Disease | focal segmental glomerulosclerosis (biomarker_via_orthology) | 8.09e-04 | 12 | 105 | 2 | DOID:1312 (biomarker_via_orthology) | |
| Disease | monocyte count | CRYBG2 STAB2 STAG1 HLA-B HLA-C SZT2 LCT TMEM87A CAPN10 SGK3 GCLC CNTN5 ARHGAP25 | 8.27e-04 | 1320 | 105 | 13 | EFO_0005091 |
| Disease | Amino Acid Metabolism, Inherited Disorders | 9.54e-04 | 13 | 105 | 2 | C0750905 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 9.54e-04 | 13 | 105 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 9.54e-04 | 13 | 105 | 2 | DOID:10941 (biomarker_via_orthology) | |
| Disease | Amino Acid Metabolism, Inborn Errors | 9.54e-04 | 13 | 105 | 2 | C0002514 | |
| Disease | skin melanoma (is_marker_for) | 9.54e-04 | 13 | 105 | 2 | DOID:8923 (is_marker_for) | |
| Disease | alcohol use disorder (biomarker_via_orthology) | 1.11e-03 | 14 | 105 | 2 | DOID:1574 (biomarker_via_orthology) | |
| Disease | Diabetic Neuralgia | 1.11e-03 | 14 | 105 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 1.11e-03 | 14 | 105 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 1.11e-03 | 14 | 105 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 1.11e-03 | 14 | 105 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 1.11e-03 | 14 | 105 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 1.11e-03 | 14 | 105 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 1.11e-03 | 14 | 105 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 1.11e-03 | 14 | 105 | 2 | C0271680 | |
| Disease | intracranial aneurysm (is_marker_for) | 1.11e-03 | 14 | 105 | 2 | DOID:10941 (is_marker_for) | |
| Disease | Diabetic Asymmetric Polyneuropathy | 1.11e-03 | 14 | 105 | 2 | C0393835 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 1.28e-03 | 15 | 105 | 2 | EFO_0801746 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 1.44e-03 | 136 | 105 | 4 | DOID:9352 (is_marker_for) | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 1.46e-03 | 16 | 105 | 2 | DOID:10964 (is_marker_for) | |
| Disease | temporal arteritis (is_implicated_in) | 1.46e-03 | 16 | 105 | 2 | DOID:13375 (is_implicated_in) | |
| Disease | endometriosis (biomarker_via_orthology) | 1.46e-03 | 16 | 105 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | Huntington's disease (biomarker_via_orthology) | 1.46e-03 | 16 | 105 | 2 | DOID:12858 (biomarker_via_orthology) | |
| Disease | Profound Mental Retardation | 1.56e-03 | 139 | 105 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.56e-03 | 139 | 105 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.56e-03 | 139 | 105 | 4 | C0917816 | |
| Disease | Bipolar Disorder | 1.61e-03 | 477 | 105 | 7 | C0005586 | |
| Disease | susceptibility to cold sores measurement | 1.63e-03 | 65 | 105 | 3 | EFO_0008402 | |
| Disease | bipolar I disorder | 1.64e-03 | 141 | 105 | 4 | EFO_0009963 | |
| Disease | Pulmonary Emphysema | 1.65e-03 | 17 | 105 | 2 | C0034067 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 1.65e-03 | 17 | 105 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 1.65e-03 | 17 | 105 | 2 | DOID:11984 (is_marker_for) | |
| Disease | urate measurement, bone density | 1.68e-03 | 619 | 105 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | sphingosine 1-phosphate measurement | 1.85e-03 | 18 | 105 | 2 | EFO_0800185 | |
| Disease | Oral Submucous Fibrosis | 1.85e-03 | 18 | 105 | 2 | C0029172 | |
| Disease | platelet-to-lymphocyte ratio | 1.93e-03 | 363 | 105 | 6 | EFO_0008446 | |
| Disease | serum metabolite measurement | CYP26B1 HLA-C KDM4C CYP4B1 DNAJC16 WNT3 PARD3B SH3BP4 SERPINB13 STK39 | 2.01e-03 | 945 | 105 | 10 | EFO_0005653 |
| Disease | squamous cell carcinoma (is_marker_for) | 2.06e-03 | 19 | 105 | 2 | DOID:1749 (is_marker_for) | |
| Disease | alpha-tocopherol measurement | 2.29e-03 | 20 | 105 | 2 | EFO_0007898 | |
| Disease | erythrocyte measurement | 2.29e-03 | 257 | 105 | 5 | EFO_0005047 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.36e-03 | 74 | 105 | 3 | DOID:3748 (is_marker_for) | |
| Disease | tonsillectomy risk measurement | 2.41e-03 | 260 | 105 | 5 | EFO_0007924 | |
| Disease | stem Cell Growth Factor beta measurement | 2.45e-03 | 75 | 105 | 3 | EFO_0008292 | |
| Disease | COVID-19 (is_implicated_in) | 2.52e-03 | 21 | 105 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 2.52e-03 | 21 | 105 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | carotid artery disease (is_implicated_in) | 2.77e-03 | 22 | 105 | 2 | DOID:3407 (is_implicated_in) | |
| Disease | feeling miserable measurement | 2.85e-03 | 79 | 105 | 3 | EFO_0009598 | |
| Disease | Glioblastoma | 2.85e-03 | 79 | 105 | 3 | C0017636 | |
| Disease | Drug-Induced Liver Disease | 3.27e-03 | 404 | 105 | 6 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 3.27e-03 | 404 | 105 | 6 | C3658290 | |
| Disease | Hepatitis, Toxic | 3.27e-03 | 404 | 105 | 6 | C0019193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGLFAQDRDPRFSEI | 546 | P27540 | |
| DEVEPRESVFTNERF | 221 | O43709 | |
| FDPAELRAASATREQ | 106 | Q00973 | |
| RELFRDAAFPAADSS | 11 | Q9HC96 | |
| AEEASFRDQPVFFRE | 1796 | Q96BY7 | |
| VFNEFPSFVAEDSRR | 231 | O94779 | |
| DPETVDDAFARAFQV | 136 | P08253 | |
| QRRAAETSDDDLIPF | 856 | Q5TC82 | |
| EVNDDILARAFSRFP | 391 | Q9BTD8 | |
| DPEREVTFLEASRFA | 126 | P61018 | |
| DTQFLRFDSDAAIPR | 51 | P30511 | |
| QFVRFDSDDASPREE | 56 | P01893 | |
| QAGREEDPFRSTAEA | 21 | Q9Y6F1 | |
| SELSPEDQRVFNFDV | 411 | Q96K12 | |
| AVAVARADEAEAPFA | 66 | Q9Y5R2 | |
| DLPRAVIDDAFARAF | 131 | P14780 | |
| ADRQSPDAFETEVAA | 96 | Q8TEW8 | |
| SDTDPRELEAFAERF | 261 | Q01851 | |
| DTQFVRFDNDAASPR | 51 | P13747 | |
| RFRVDEEFQSPFASQ | 141 | P48645 | |
| SPAEVRDLDFANDAS | 436 | Q14643 | |
| DVNPEEFVNRFFDSL | 156 | P78333 | |
| RAEFPELAAFASTQR | 921 | Q5JYT7 | |
| ARFFANPVSREDEES | 491 | Q8WWW8 | |
| VFDPDRFSQARSEDK | 411 | Q9NR63 | |
| DARSLEFAFQPETEE | 201 | Q5SZK8 | |
| TERQADFTAEKFPDE | 156 | Q5JVS0 | |
| QFVRFDSDAASPRGE | 56 | P10321 | |
| VAPDEFSSREEFVVA | 791 | P27815 | |
| PFIETFTEDDEASRA | 216 | P48506 | |
| FHFPFNSERRDSIDE | 126 | Q9Y2G8 | |
| VANTFREFALSETPD | 1596 | Q6ZR08 | |
| SFSRDTFPEDIVSRD | 916 | Q9H3R0 | |
| RAERDAFLQDTFPEG | 371 | P09848 | |
| LTDPRSESERVEFFN | 581 | Q93074 | |
| DRVEDPADSASFFPD | 161 | Q96PP8 | |
| SNFAPTVERDEFLVA | 41 | Q96CW5 | |
| RPSDRDAFLEEFRTS | 601 | O15287 | |
| QFVRFDSDAASPREE | 56 | P01889 | |
| ASPLVRFERFDREDD | 2476 | Q7Z6Z7 | |
| FSLDTVINPDDRVFE | 86 | Q86U28 | |
| EQARDVVSFEQPEFS | 986 | P16144 | |
| FREALQFEIDDSSPS | 186 | Q86UY6 | |
| FKTAFSENEDDESRP | 946 | Q9ULT8 | |
| PDIDEDEITASFRRF | 341 | Q7Z5Q1 | |
| FEDFEERFAAATPNR | 246 | O75553 | |
| PFRFEDLVTDEETAS | 211 | O95727 | |
| IFELRRIAFDAESDP | 316 | Q96JJ3 | |
| NVDPDESARISSAFF | 1221 | Q13698 | |
| DPAAFESRLEKRSEF | 91 | Q5TC12 | |
| RDQFSPDDFLGRTEI | 1666 | Q15811 | |
| FSFEDDQAALPASFR | 1371 | Q8N1P7 | |
| RERAAEVFFETFNVP | 121 | P61163 | |
| SIRREDRATFAFSPE | 51 | Q9UHN6 | |
| DPRDFKRTDDFEESN | 951 | Q6MZM0 | |
| EIRTIASDPDERFFF | 321 | O75578 | |
| ASDPDERFFFNVTDE | 326 | O75578 | |
| ISAFANDPDVTREAA | 151 | Q6UW01 | |
| PDIDEDEITASFRRF | 481 | Q17RY0 | |
| DPEVFDSLRFSTENA | 421 | P13584 | |
| RAPSLTNDEVEEFRA | 536 | Q13206 | |
| AGPDDIRNFDTAFTE | 441 | Q96BR1 | |
| PSSETQEEFVDDFRV | 46 | P30622 | |
| FREPADAERVLAQAD | 56 | Q53GL7 | |
| KTQVFRRFPDDDDES | 376 | Q99983 | |
| VPDFERSFFNRNPSE | 376 | Q9UPX6 | |
| TFPFDEALRDITAAR | 2761 | Q5T011 | |
| FPRGRDSEDFNVKEE | 136 | Q9BZE2 | |
| SVQVPDDQDFRSFRS | 21 | Q9Y365 | |
| DVLRAAAFSPADQDD | 946 | Q9P0V3 | |
| FRDIAPSEEAINDRT | 1051 | Q58EX7 | |
| DRPSEEVFSRDLSDF | 336 | Q9H6L5 | |
| VDADPRDLEAFAERF | 251 | Q12837 | |
| LQIDFADPSRADDAR | 91 | P04899 | |
| REGDEQRTFFSFPAV | 596 | P41250 | |
| AQRRSFTPASFLEED | 236 | Q96CC6 | |
| FENASQTFDDLPARF | 41 | O43567 | |
| AEEFPNLAVASERRD | 406 | Q96T21 | |
| DETQPTRFAFVEFAD | 101 | Q8WXA9 | |
| INDFDFPEQSISRDD | 331 | Q96N87 | |
| EFANSFDIPDDRAAS | 1416 | Q9UPX8 | |
| ADPEEATAARVIDRF | 26 | Q9NY61 | |
| RAPSEDVFAFDLSSN | 316 | Q969H4 | |
| PEGSSEEREAFTRAN | 446 | P21980 | |
| ESSSAFPDNAARREV | 86 | Q12933 | |
| EFSRFVDLEGEEPRS | 391 | Q6B0B8 | |
| AFRSVPLAEEEDFDS | 526 | Q5TCY1 | |
| SLEPVDFVNAADESR | 131 | Q9UIV8 | |
| FDDTEREPDQTFSLN | 116 | Q9GZP4 | |
| FFPSQEHEATREDER | 86 | Q96LM6 | |
| FNFRASAEPPTNEAE | 896 | Q9P2F5 | |
| RDAFDAGERPSFDRD | 211 | P42331 | |
| RDEVAEAQRAEFSPA | 116 | Q8N5U6 | |
| FEDNDSRRDSLFVPH | 601 | Q99250 | |
| EFADARENRPDARSA | 171 | P56703 | |
| TVFAPLSAAFDEEAR | 1631 | Q8WWQ8 | |
| RERAELRPDFFDSAA | 1231 | Q8WVM7 | |
| TAAFEERRFPSSFEE | 436 | Q15149 | |
| ISSDAFFPFRDNVDR | 536 | P31939 | |
| QESRFDIVFADAVFP | 141 | O75310 | |
| DDQFSVERPDGSNFT | 81 | A0A1B0GX68 | |
| FDFVIDENAPVTERA | 751 | P54278 | |
| RGRSAFQEEDFPALV | 476 | Q86UK7 | |
| AESPAQRFEARIEDG | 246 | Q9H7L9 | |
| SVQFEGAERPSFREE | 341 | Q5VZ18 | |
| NDIRFEFTPGRDTAD | 466 | Q9UEW8 | |
| PHFSSFSRDVREERD | 166 | Q8NG27 | |
| SENPSDVFRFLVEER | 466 | Q92995 | |
| NQRFAFSPLSEEEEE | 466 | Q8NBN3 |